EGFR and neoplasm: These protocols combine quantitative imaging features (tumor volume, peritumoral edema, diffusion/perfusion parameters) with molecular data (EGFR mutation status, TTF-1/napsin A expression) and treatment history to predict recurrence likelihood or adverse radiation effects (AREs) after SRS [146,147].